Helix Biomedix Stock Market Value
| HXBM Stock | USD 2.00 0.70 25.93% |
| Symbol | Helix |
Helix BioMedix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Helix BioMedix's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Helix BioMedix.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Helix BioMedix on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Helix BioMedix or generate 0.0% return on investment in Helix BioMedix over 30 days. Helix BioMedix is related to or competes with Orgenesis. Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States More
Helix BioMedix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Helix BioMedix's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Helix BioMedix upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 25.93 | |||
| Value At Risk | (3.23) |
Helix BioMedix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Helix BioMedix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Helix BioMedix's standard deviation. In reality, there are many statistical measures that can use Helix BioMedix historical prices to predict the future Helix BioMedix's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.05) | |||
| Total Risk Alpha | (1.61) | |||
| Treynor Ratio | 2.02 |
Helix BioMedix Backtested Returns
Helix BioMedix holds Efficiency (Sharpe) Ratio of -0.19, which attests that the entity had a -0.19 % return per unit of risk over the last 3 months. Helix BioMedix exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Helix BioMedix's Risk Adjusted Performance of (0.15), market risk adjusted performance of 2.03, and Standard Deviation of 4.82 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.54, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Helix BioMedix are expected to decrease at a much lower rate. During the bear market, Helix BioMedix is likely to outperform the market. At this point, Helix BioMedix has a negative expected return of -0.78%. Please make sure to check out Helix BioMedix's variance, skewness, as well as the relationship between the Skewness and day typical price , to decide if Helix BioMedix performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.82 |
Very good predictability
Helix BioMedix has very good predictability. Overlapping area represents the amount of predictability between Helix BioMedix time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Helix BioMedix price movement. The serial correlation of 0.82 indicates that around 82.0% of current Helix BioMedix price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
Helix BioMedix lagged returns against current returns
Autocorrelation, which is Helix BioMedix pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Helix BioMedix's pink sheet expected returns. We can calculate the autocorrelation of Helix BioMedix returns to help us make a trade decision. For example, suppose you find that Helix BioMedix has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Helix BioMedix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Helix BioMedix pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Helix BioMedix pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Helix BioMedix pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Helix BioMedix Lagged Returns
When evaluating Helix BioMedix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Helix BioMedix pink sheet have on its future price. Helix BioMedix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Helix BioMedix autocorrelation shows the relationship between Helix BioMedix pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Helix BioMedix.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Helix Pink Sheet
Helix BioMedix financial ratios help investors to determine whether Helix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioMedix security.